STEPHANIE LEONARDSON: Open Payments
NPI 1194128025 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 31 payments from 14 companies in 2025. Trend: 2023 $1,559 · 2024 $1,664 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $180 |
| Actelion Pharmaceuticals US, Inc. | 3 | $144 |
| United Therapeutics Corporation | 2 | $139 |
| Boston Scientific Corporation | 5 | $135 |
| Medtronic, Inc. | 3 | $99 |
| Amgen Inc. | 1 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| Abbott Laboratories | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: WINREVAIR, UPTRAVI, WATCHMAN FLX, TYVASO, REPATHA, SYMPLICITY G3, LEQVIO, FARXIGA.
Industry payments across ID — which companies pay providers there.
